Try our mobile app

General information

Country: UNITED STATES

Sector: Drug Manufacturers — General

Categories: @vaccine-makers   

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Website: jnj.com


  • Bad financial results growth rate -46.7% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (16.2%)
  • Dividend yield for the last twelve months 2.0%
  • Free cash flow yield -1.2% (LTM)
  • Share price is 83.8% higher than minimum and 2.3% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (29.1x vs
    )

Key Financials (Download financials)

Ticker: JNJ
Share price, USD:  (+0.1%)261.06
year average price 219.53  


year start price 174.72 2025-08-14

min close price 174.16 2025-09-18

max close price 267.24 2026-07-07

current price 259.92 2026-08-13
Common stocks: 2 631 399 832

Dividend Yield:  2.0%
FCF Yield LTM: -1.2%
EV / LTM EBITDA: 29.1x
Target EV / EBITDA (hist percentile):
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 686 953
Net Debt ($m): 32 936
EV (Enterprise Value): 719 889
EBITDA LTM ($m): 24 701
EV / LTM EBITDA: 29.1x
Price to Book: 8.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-02-08fool.com

What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.

2026-02-06businesswire.com

Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium

2026-02-03forbes.com

What's Behind The 50% Surge In JNJ Stock?

2026-02-03globenewswire.com

Johnson & Johnson Launches the First and Only Daily Disposable Multifocal Toric Contact Lens for Astigmatic Patients with Presbyopia in United Kingdom and Ireland

2026-02-01defenseworld.net

Winnow Wealth LLC Has $1.71 Million Position in Johnson & Johnson $JNJ

2026-01-30fool.com

This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy?

2026-01-30seekingalpha.com

Johnson & Johnson: Fraud Claim Dismissal Today Is Not A Sign Talc Litigation Is Over

2026-01-29reuters.com

US judge tosses lawsuit accusing J&J of fraud over talc bankruptcy strategy

2026-01-28zacks.com

Should You Stay Invested in J&J Stock After Q4 Beat & Solid Guidance?

2026-01-28seekingalpha.com

Johnson & Johnson: Strong Momentum Heading Into 2026
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data